1-20 of 44
Katharina Götze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1 -Mutated Acute Myeloid Leukemia

Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser
Journal: Blood
Blood (2022) 140 (Supplement 1): 2010–2013.
https://doi.org/10.1182/blood-2022-166084
Published: 2022
Journal Articles

Phase I Study of the LSD1 Inhibitor Tranylcypromine (TCP) in Combination with All- Trans Retinoic Acid (ATRA) and Low-Dose Cytarabine (LDAC) in Elderly, Medically Non-Fit Patients with AML or High-Risk MDS (TRANSATRA trial)

Michael Lübbert, Claudia Schmoor, Tobias Berg, Michael Kruszewski, Marcus Matthias Schittenhelm, Katharina Götze, Caroline Pabst, Andrea Kündgen, Tobias Ma, Anna Frey, Kevin Moschallski, Usama-Ur Rehman, Johannes Jung, Justus Duyster, Manfred Jung, Roland Schüle, Ralph Wäsch, Olga Grishina
Journal: Blood
Blood (2022) 140 (Supplement 1): 9087–9088.
https://doi.org/10.1182/blood-2022-159471
Published: 2022
Journal Articles

Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?

Sofía M Toribio Castelló, Felix Lopez-Cadenas, Claude Preudhomme, Angela Villaverde Ramiro, Laurène Fenwarth, Eva Lumbreras, Teresa González, Mónica Del Rey, Blanca Xicoy, Aline Renneville, Joaquín Sánchez-Garcia, Rosa Coll, Bohrane Slama, José Ángel Hernández-Rivas, Sylvain Thepot, Teresa Bernal, Agnès Guerci-Bresler, Katharina Götze, Jesús María Hernández-Rivas, Pierre Fenaux, Consuelo Del Cañizo, Maria Diez-Campelo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9740–9743.
https://doi.org/10.1182/blood-2022-168599
Published: 2022
Journal Articles

Risk Prediction in MDS: A Validation of the IPSS-M and Comparison to IPSS-R and to Two Other Personalized Prediction Tools

Constance Baer, Sandra Huber, Stephan Hutter, Manja Meggendorfer, Niroshan Nadarajah, Wencke Walter, Uwe Platzbecker, Katharina Götze, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann, Claudia Haferlach
Journal: Blood
Blood (2022) 140 (Supplement 1): 1128–1129.
https://doi.org/10.1182/blood-2022-159939
Published: 2022
Journal Articles

A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodysplastic Syndrome

Amer M. Zeidan, MBBS, MHS, Daniel A Pollyea, MD, Jacqueline S Garcia, MD, Andrew Brunner, MD, Fernando Roncolato, BMed, FRACP, FRCPA, Uma Borate, MD, Olatoyosi Odenike, MD, Ashish R. Bajel, FRACP, Anne Marie Watson, FRACP, FRCPA, MBBS, Katharina Götze, Florian Nolte, MD, Peter T. Tan, MBBS, Wan-Jen Hong, MD, Martin Dunbar, DRPH, MS, Ying Zhou, PhD, Lori Gressick, BS, William Ainsworth, PhD, Jason Harb, PhD, Ahmed Hamed Salem, PhD FCP, John Hayslip, Ronan Swords, MD PhD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 565.
https://doi.org/10.1182/blood-2019-124994
Published: 2019
Journal Articles

Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial

Uwe Platzbecker, MD, Jan Moritz Middeke, MD, Katja Sockel, MD, Regina Herbst, MD, Lars R. Fransecky, MD, Dominik Wolf, MD, Schumacher Martin, MD, Alwin Krämer, MD, Richard Noppeney, MD, Juergen Novotny, MD, Gesine Bug, Katharina Götze, Karsten Spiekermann, MD, Matthias Stelljes, MD, Christoph Groth, MD, Marion Subklewe, MD, Antje Schubert, Anke Mütherig, MD, Tilmann Bochtler, MD, Marika Mende, MD, Anne Sophie Kubasch, MD, Mathias Hänel, MD, Ulrich Dührsen, Prof, MD PhD, Johannes Schetelig, MD MSc, Christoph Röllig, MD MSC, Claudia D Baldus, Gerhard Ehninger, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Michael Kramer, M.Sc., Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 644.
https://doi.org/10.1182/blood-2019-129926
Published: 2019
Journal Articles

The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism

Michael Heider, Ruth Eichner, Jacob Stroh, Anna Kuisl, Jana Zecha, Jannis Lawatscheck, Martina Rudelius, Anne-Kathrin Garz, Simone Lemeer, Christian Peschel, Ulrich Keller, MD, Katharina Götze, Johannes Buchner, Bernhard Kuster, Vanesa Fernandez-Saiz, Florian Bassermann, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 314.
https://doi.org/10.1182/blood-2019-129064
Published: 2019
Journal Articles

Biomarkers of Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia - Results of the Europe Trial By the Emsco Network

Uwe Platzbecker, MD, Anne Sophie Kubasch, MD, Aristoteles Giagounidis, MD, Georgia Metzgeroth, Anna Jonasova, MD PhD, Regina Herbst, MD, Jose Miguel Torregrosa Diaz, Benoit De Renzis, MD, Katharina Götze, Marie-Luise Huetter-Kroenke, MD, Marie-Pierre Gourin, Borhane Slama, MD, Sophie Dimicoli-Salazar, MD, Pascale Cony-Makhoul, MD, Kamel Laribi, MD, Sophie Park, MD PhD, Katja Jersemann, Oliver Tiebel, MD, Katja Sockel, MD, Silke Gloaguen, MSc, Anna Mies, Fatiha Chermat, Christian Thiede, MD, Rosa Sapena, Richard F. Schlenk, MD, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2998.
https://doi.org/10.1182/blood-2019-129047
Published: 2019
Journal Articles

Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1 - RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)

Frank G. Rücker, MD, Mridul Agrawal, MDMSc, Andrea Corbacioglu, PhD, Daniela Weber, Silke Kapp-Schwoerer, MD, Verena I. Gaidzik, MD, Nikolaus Jahn, MD, Thomas Schroeder, MD, Mohammad Wattad, MD, Michael Lübbert, Elisabeth Koller, MD, Thomas Kindler, MD, Katharina Götze, Mark Ringhoffer, MD, Jörg Westermann, MD, Walter Fiedler, MD, Heinz A. Horst, MD, Richard Greil, MD, Roland Schroers, Karin Mayer, MD, Thomas Heinicke, MD, Jürgen Krauter, MD, Richard F. Schlenk, MD, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, Peter Paschka, MD, Hartmut Döhner, MD, Konstanze Döhner
Journal: Blood
Blood (2019) 134 (Supplement_1): 2740.
https://doi.org/10.1182/blood-2019-125584
Published: 2019
Journal Articles

Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

Frank G. Rücker, Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp-Schwoerer, Verena I. Gaidzik, Nikolaus Jahn, Thomas Schroeder, Mohammed Wattad, Michael Lübbert, Elisabeth Koller, Thomas Kindler, Katharina Götze, Mark Ringhoffer, Jörg Westermann, Walter Fiedler, Heinz A. Horst, Richard Greil, Roland Schroers, Karin Mayer, Thomas Heinicke, Jürgen Krauter, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Peter Paschka, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2019) 134 (19): 1608–1618.
https://doi.org/10.1182/blood.2019001425
Published: 2019
Includes: Supplemental data
Journal Articles

Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG)

Mridul Agrawal, MD, Andrea Corbacioglu, PhD, Peter Paschka, MD, Daniela Weber, Verena I. Gaidzik, MD, Nikolaus Jahn, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Mohammad Amen Wattad, MD, Michael Lübbert, MD, Walter Fiedler, MD, Katharina Götze, MD, Mark Ringhoffer, MD, Jan Schleicher, MD, Elisabeth Lange, MD, Gerhard Held, MD, Martin Griesshammer, MD, Richard Greil, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Felicitas Thol, MD, Jürgen Krauter, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 1207.
https://doi.org/10.1182/blood.V128.22.1207.1207
Published: 2016
Journal Articles

Condensed Versus Standard Schedule of High-Dose Cytarabine Consolidation Therapy with Pegfilgrastim Growth Factor Support in Acute Myeloid Leukemia

Sonia Jaramillo, MD, Axel Benner, Jurgen Krauter, Hans Martin, MD, Thomas Kindler, MD, Martin Bentz, MD, Helmut R. Salih, MD, Gerhard Held, MD, Caus-Henning Köhne, MD, Katharina Götze, Michael Lübbert, MD, Andrea Kündgen, MD, Peter Brossart, MD, Mohammad Amen Wattad, MD, Hans-Juergen Salwender, MD, Bernd Hertenstein, MD, David Nachbaur, MD, Gerald Wulf, MD, Heinz A. Horst, MD PhD, Heinz Kirchen, MD, Walter Fiedler, MD, Aruna Raghavachar, MD, Gudrun Russ, MD, Stephan Kremers, Elisabeth Koller, MD, Volker Runde, MD, Gerhard Heil, Daniela Weber, Brigitte Schlegelberger, Prof, MD, Konstanze Döhner, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2016) 128 (22): 337.
https://doi.org/10.1182/blood.V128.22.337.337
Published: 2016
Journal Articles

Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study

Uwe Platzbecker, MD, Ulrich Germing, Katharina Götze, Philipp Kiewe, MD, Thomas Wolff, MD, Karin Mayer, MD, Joerg Chromik, MD, Markus Radsak, MD, Eileen Donovan, Dawn M. Wilson, Xiaosha Zhang, Abderrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD, Aristoteles Giagounidis
Journal: Blood
Blood (2016) 128 (22): 3168.
https://doi.org/10.1182/blood.V128.22.3168.3168
Published: 2016
Journal Articles

Phase I/II Study on Cytarabine and Idarubicin Combined with Escalating Doses of Clofarabine in Untreated Patients with Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10 CIARA)

Juergen Krauter, MD, Walter Fiedler, MD, Richard F. Schlenk, MD, Peter Paschka, MD, Felicitas Thol, MD, Michael Lübbert, MD, Mohammad Amen Wattad, MD, Mareike Verbeek, Christian Koenecke, MD, Barbara Neuhaus, Maxim Kebenko, Melanie Janning, Konstanze Dohner, MD, Verena I. Gaidzik, MD, Heiko Becker, MD, Christine Greil, MD, Peter Reimer, MD, Katharina Götze, MD, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2016) 128 (22): 4038.
https://doi.org/10.1182/blood.V128.22.4038.4038
Published: 2016
Journal Articles

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Stefanie Jilg, MD, Johanna Kauschinger, MDcal student, Veronika Reidel, MDcal student, Catharina Müller-Thomas, MD, Richard Hauch, MDcal student, Johannes Schauwecker, MD, Burkhard Schmidt, MD, Ulrike Höckendorf, Dipl. Humanbiol., Christian Peschel, MD, Katharina Götze, MD, Philipp J. Jost, MD
Journal: Blood
Blood (2016) 128 (22): 4297.
https://doi.org/10.1182/blood.V128.22.4297.4297
Published: 2016
Journal Articles

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Stefan Habringer, MD, Peter Herhaus, Margret Schottelius, PhD, Constantin Lapa, MD, Rouzanna Istvanffy, PhD, Katharina Götze, Katja Steiger, DVM, Binje Vick, PhD, Christian Peschel, MD, Robert Oostendorp, PhD, Irmela Jeremias, MD, Hans-Jürgen Wester, PhD, Goetz Ulrich Grigoleit, MD, Ulrich Keller, MD
Journal: Blood
Blood (2016) 128 (22): 4055.
https://doi.org/10.1182/blood.V128.22.4055.4055
Published: 2016
Journal Articles

Luspatercept Response in ESA-NaïVe/RS+ Patients and RS- Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS)

Uwe Platzbecker, Ulrich Germing, Katharina Götze, Philipp Kiewe, MD, Thomas Wolff, MD, Karin Mayer, MD, Joerg Chromik, MD, Markus Radsak, MD, Eileen Donovan, Dawn M. Wilson, Xiaosha Zhang, Abderrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD, Aristoteles Giagounidis
Journal: Blood
Blood (2016) 128 (22): 5551.
https://doi.org/10.1182/blood.V128.22.5551.5551
Published: 2016
Journal Articles

Results of the Randomized Phase II Study Decider (AMLSG 14-09) Comparing Decitabine (DAC) with or without Valproic Acid (VPA) and with or without All- Trans Retinoic Acid (ATRA) Add-on in Newly Diagnosed Elderly Non-Fit AML Patients

Michael Lübbert, MD, Olga Grishina, Claudia Schmoor, Richard F. Schlenk, MD, Edgar Jost, Jürgen Krauter, MD, Michael Heuser, MD, Felicitas Thol, MD, Marcus M. Schittenhelm, Helmut R. Salih, Andrea Kündgen, MD, Ulrich Germing, Katharina Götze, Hans-Walter Lindemann, Carsten Müller-Tidow, Gerhard Heil, Gesine Bug, Carsten Schwänen, Aristoteles Giagounidis, Sebastian Scholl, Andreas Neubauer, Wolfram Brugger, Maike de Wit, Sebastian Schroll, Stephan Kremers, Elisabeth Lange, MD, Johannes Kullmer, Dirk Behringer, Matthias Egger, Irmgard Dresel, Tobias Dechow, Dietger Niederwieser, MD, Maxi Wass, Annette M. May, Ralph Wäsch, MD, Konstanze Döhner, Arnold Ganser, MD, Björn Hackanson, Hartmut Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 589.
https://doi.org/10.1182/blood.V128.22.589.589
Published: 2016
Journal Articles

Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML)

Peter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, Tibor Vag, Carlos Gerngroß, Alexander Höllein, Torben Altmann, Catharina Müller-Thomas, Julia Slotta-Huspenina, Christian Peschel, Markus Schwaiger, Hans-Jürgen Wester, Mareike Verbeek, Karsten Spiekermann, Katharina Götze, Ulrich Keller
Journal: Blood
Blood (2015) 126 (23): 1275.
https://doi.org/10.1182/blood.V126.23.1275.1275
Published: 2015
Journal Articles

Pharmacodynamic Monitoring of the Efficacy of a Targeted Therapy with Midostaurin By Plasma Inhibitor Activity (PIA) Analysis in FLT3 -ITD Positive AML Patients within the AMLSG 16-10 Trial: A Study of the AML Study Group (AMLSG)

Frauke Theis, Peter Paschka, MD, Daniela Weber, Verena I. Gaidzik, MD, Lars Bullinger, MD, Maria-Veronica Teleanu, MD, Gudrun Göhring, MD, Helmut R. Salih, MD, Andrea Kündgen, Hans-Juergen Salwender, MD, Joerg Westermann, MD, Walter Fiedler, MD, Katharina Götze, Heinz-August Horst, MD PhD, Gerald G Wulf, MD, Michael Luebbert, MD, Dominik Wolf, MD, Thomas Kindler, MD, Mark Ringhoffer, MD, Doris Kraemer, MD, Jürgen Krauter, MD, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2015) 126 (23): 2585.
https://doi.org/10.1182/blood.V126.23.2585.2585
Published: 2015